Genedata AG
Discovery informatics for biotech, pharmaceuticals and the life sciences. The Company offers expertise in research informatics combined with open and
scalable computational solutions.
Founded in 1997 as a privately held spin off from Novartis, Genedata is headquartered in Basel, Switzerland and has branches in Tokyo (Japan), Munich (Germany), Boston (USA) and San Francisco (USA). The Company is also represented in Taiwan and Singapore.
Dr. Othmar Pfannes, CEO
Dr. Peter Haberl, Managing Director Germany
Dr. Jens Hoefkens, Managing Director USA
Dr. Frank Staubli, Managing Director Japan
Dr. Juerg Poschet, Chairman
Dr. Reinhard Ambros, Non-Executive Director
Dr. Othmar Pfannes, Executive Director
Dr. Hugo Fluehler, Non-Executive Director
Dr. Eric Menotti, Non-Executive Director
Maulbeerstrasse 46
CH-4016 Basel
Switzerland
Phone: +41-61-697-6099
Fax: +41-61-697-7244
Modular compuational platforms Genedata Phylosopher(R) for integrating, structuring, and analyzing research data; Genedata Screener(R) for high throughput screening analysis; and Genedata Expressionist(R) for omics data integration, processing and analysis.
Related news
- InnoMed PredTox Consortium Presents Final Results From Non-clinical Safety Studies
- Genedata Screener 6.0 Expands into Time Series Data Analysis with New Kinetics Analyzer Module
- Genedata and Axxam Announce High Throughput Screening Data Analysis Collaboration
- New Screen-to-Lead Data Analysis and Management Platform Genedata Screener® 5.5 Release
- Genedata Expands Affymetrix GeneChip-compatibleTM Status for Exon Expression on GeneChip® Microarray Platform
- Genedata and Roche Join Forces in Proteomics Process
- How to Perform Automated High-Throughput MS Data Processing
- Genedata Provides Expressionist Platform to Eisai Research Institute
- Multi-Year Contract Extension with Nycomed for Genedata Screener
- Genedata Provides Expressionist Platform to U.S. Food and Drug Administration
- Research IT Partnership with Nycomed Expands Genedata`s Business Model
- Genedata Joins Japanese Research Initiative for Metastatic Biomarkers
- New Data Analysis and Management Solution Genedata Screener 5.0 Increases Productivity from Screen to Leads
- InnoMed Drug Safety Experts Begin Mechanistic Investigations
- Genedata Joins Henkel in White Biotech Initiative
- Genedata Announces Agreement with the Fiehn Laboratory at UC Davis for Refiner MS and Analyst Software
- Genedata provides Data Management and Analysis Platform for Systems Biology Initiative FRISYS
- UCB Selects Genedata to Manage Drug Target Information
- Gene Logic Reports First Quarter 2007 Financial Results
- Scientists at Genedata Enhance Cell Based Screening Workflow
- Genedata releases ToxPedia™ for Systems Toxicology
- Genedata joins European Systems Biology Initiative BaSysBio
- Genedata in Screening Analysis Collaboration with Chugai in Japan
- Genedata Expands Collaboration with HepatoSys Systems Biology Network
- New Release Genedata Expressionist Strengthens Cross-Omics Technology Integration for Biomarker Discovery
- Genedata and ChemAxon Integrate Lead Discovery Technologies
- Expansion of Genedata’s Collaboration with Serono into High Content Screening
- Genedata Installs Large-Scale Analysis Platform at Wyeth Pharma
- Genedata Collaboration Yields New Hit to Lead Solution
- Integrated Workflow Created Between Genedata and Ingenuity Software
- Gene Logic Reports Second Quarter 2006 Financial Results
- Genedata and Insilico Biotechnology in Systems Biology Collaboration
- Genedata Collaborates with HepatoSys Systems Biology Competence Network
- Genedata Collaborates with €12.6M European Cancer Research Consortium
- Genedata Collaborates with Kluyver Centre for Genomics of Industrial Fermentation
- Enabling High-throughput Titration Response Experiments at the NIH Chemical Genomics Center
- Bayer HealthCare Selects Genedata´s Bioinformatic Platform for its Target Research and Biomarker Activities